ArticleInternational journal of medical sciences2018

RIPK1 Inhibition Enhances Pirarubicin Cytotoxic Efficacy through AKT-P21-dependent Pathway in Hepatocellular Carcinoma.

Hechen Huang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.